April 30, 2025
Back in 2000, health experts declared measles had been eliminated from the United States thanks to an ambitious measles-mumps-rubella (MMR) vaccination program for children. But as […]
April 29, 2025
Today, the US Food and Drug Administration (FDA) approved prademagene zamikeracel cellular sheets (pz-cel, Zevaskyn), the first autologous cell-based gene therapy for treating wounds in adults […]
April 29, 2025
The US Food and Drug Administration (FDA) has approved a new indication for upadacitinib as a treatment for giant cell arthritis (GCA) in adults. This is […]
April 29, 2025
INCHEON, South Korea — A randomized controlled trial of physical therapy (PT) for pain relief in people with meniscal tear and osteoarthritis found no significant difference […]
April 29, 2025
People of all ages now grow up — and grow old — immersed in digital screens, generating concerns about the potential effects on the brain. On […]
April 29, 2025
TOPLINE: Women with polyhydramnios faced a higher risk for postpartum haemorrhage (PPH), with caesarean section delivery and foetal macrosomia serving as independent risk factors and prophylactic […]
April 29, 2025
TOPLINE: More than 50% of patients with primary aldosteronism had hyperparathyroidism (HPT), primarily secondary HPT. These patients also exhibited higher rates of atrial fibrillation and hypokalaemia, […]
April 29, 2025
TOPLINE: Despite an increase in prescription rates of mineralocorticoid receptor antagonists (MRAs) for patients with heart failure with reduced ejection fraction (HFrEF) in the United Kingdom […]
April 29, 2025
Elisa Zenni, MD, recalls the process of completing her fellowship training in Boston, while at the same time, trying to land her first job in academic […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669
Next page